Rita Milazzo, PhD, is a senior researcher with over 15 years of experience in the field of hematopoietic stem and progenitor cell (HSPC) gene therapy for neurodegenerative and autoimmune diseases.

She developed her carrier working at the San Raffaele Telethon Institute for Gene Therapy in Milano, where she focused on the identification of critical factors enhancing HSPC-based transplant procedures for diseases with severe nervous system involvement.

Her research contributed to the development of innovative strategies for the treatment of neurological genetic diseases and in the translation of pre-clinical data into the design of human clinical trials, as in the case of metachromatic leukodystrophy.

Her work is published in peer-reviewed journals in the field of cell and gene therapy.

No Comments

Sorry, the comment form is closed at this time.